Texas-founded partnership debuts a 12-week GLP-1 + food-as-medicine program built for sustainable metabolic health and employer-ready deploymentAUSTIN, ...

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the ...

More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like pepti ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

The Trump administration placed new security requirements on Nividia's semiconductor sales to China, but essentially ...

FDA moves to strike suicide risk warnings from Saxenda, Wegovy, and Zepbound labels after analysis finds no increased risk.

Compared with cessation of behavioral weight management programs, weight regain was faster after cessation of medications (by 0.3 kg/month), independent of initial weight loss.

Georgia's governor said Wednesday that he wants to spend $1.8 billion to unclog one of traffic-choked Atlanta's notorious ...

After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...